ADH5 and hepatocellular carcinoma: Nevertheless, it is worth to note that the mean size of GSNOR-deficient tumor xenografts is larger (approximately the double) than parental (GSNOR-proficient) HCC (32), suggesting that excessive S-nitrosylation arising from GSNOR loss, might promote tumor progression and growth in vivo.